Gossamer Bio

9.79
开盘价
9.40
市值
58.75M+
最高价
9.77
最低价
9.00
收盘价
9.61
成交量
144.83K+
市盈率
-0.16
股息率
0.00%

Gossamer Bio简介

Gossamer Bio,Inc.致力于发现、获得、开发免疫学、炎症和肿瘤学疾病领域的治疗药物,并将其商业化。它的主要候选产品GB001旨在治疗中到重度嗜酸性哮喘和其他过敏性疾病。该公司由Faheem Hasnain和Sheila Gujrathi于2015年10月25日创立,总部位于加利福尼亚州圣地亚哥。

如何购买 Gossamer Bio (GOSS)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 GOSS

购买 GOSS

通过 RockFlow App 或网页端搜索 GOSS,输入您想要投资的金额,然后点击确认即可完成交易。

logo

社交媒体

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.